A

Amyris Inc
F:3A01

Watchlist Manager
Amyris Inc
F:3A01
Watchlist
Price: 0.0391 EUR Market Closed
Market Cap: €14.4m

Amyris Inc
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Amyris Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
A
Amyris Inc
F:3A01
Non-Reccuring Items
-$1.2m
CAGR 3-Years
73%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Sherwin-Williams Co
NYSE:SHW
Non-Reccuring Items
$16.2m
CAGR 3-Years
92%
CAGR 5-Years
N/A
CAGR 10-Years
32%
Dupont De Nemours Inc
NYSE:DD
Non-Reccuring Items
-$465m
CAGR 3-Years
-17%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Ecolab Inc
NYSE:ECL
Non-Reccuring Items
-$166.1m
CAGR 3-Years
-1%
CAGR 5-Years
11%
CAGR 10-Years
10%
PPG Industries Inc
NYSE:PPG
Non-Reccuring Items
-$35m
CAGR 3-Years
49%
CAGR 5-Years
34%
CAGR 10-Years
13%
Albemarle Corp
NYSE:ALB
Non-Reccuring Items
-$449.4m
CAGR 3-Years
-138%
CAGR 5-Years
-53%
CAGR 10-Years
-14%
No Stocks Found

Amyris Inc
Glance View

Market Cap
14.4m EUR
Industry
Chemicals

Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.

3A01 Intrinsic Value
Not Available

See Also

What is Amyris Inc's Non-Reccuring Items?
Non-Reccuring Items
-1.2m USD

Based on the financial report for Dec 31, 2022, Amyris Inc's Non-Reccuring Items amounts to -1.2m USD.

What is Amyris Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
28%

Over the last year, the Non-Reccuring Items growth was 97%. The average annual Non-Reccuring Items growth rates for Amyris Inc have been 73% over the past three years , 28% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett